Literature DB >> 16822173

Recognition and signaling by toll-like receptors.

A Phillip West1, Anna Alicia Koblansky, Sankar Ghosh.   

Abstract

Toll-like receptors (TLRs) are transmembrane proteins that detect invading pathogens by binding conserved, microbially derived molecules and that induce signaling cascades for proinflammatory gene expression. A critical component of the innate immune system, TLRs utilize leucine-rich-repeat motifs for ligand binding and a shared cytoplasmic domain to recruit the adaptors MyD88, TRIF, TIRAP, and/or TRAM for downstream signaling. Despite significant domain conservation, TLRs induce gene programs that lead not only to the robust production of general proinflammatory mediators but also to the production of unique effectors, which provide pathogen-tailored immune responses. Here we review the mechanisms by which TLRs recognize pathogens and induce distinct signaling cascades.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16822173     DOI: 10.1146/annurev.cellbio.21.122303.115827

Source DB:  PubMed          Journal:  Annu Rev Cell Dev Biol        ISSN: 1081-0706            Impact factor:   13.827


  242 in total

1.  Emerging roles for multipotent, bone marrow-derived stromal cells in host defense.

Authors:  Jeffery J Auletta; Robert J Deans; Amelia M Bartholomew
Journal:  Blood       Date:  2012-01-06       Impact factor: 22.113

Review 2.  Deciphering the complexity of Toll-like receptor signaling.

Authors:  Renato Ostuni; Ivan Zanoni; Francesca Granucci
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

Review 3.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

Review 4.  Regulation of antigen uptake, migration, and lifespan of dendritic cell by Toll-like receptors.

Authors:  Ivan Zanoni; Francesca Granucci
Journal:  J Mol Med (Berl)       Date:  2010-06-18       Impact factor: 4.599

Review 5.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

6.  TIR domain-containing adaptor SARM is a late addition to the ongoing microbe-host dialog.

Authors:  Qing Zhang; Christian M Zmasek; Xiaohui Cai; Adam Godzik
Journal:  Dev Comp Immunol       Date:  2010-11-24       Impact factor: 3.636

Review 7.  Unifying themes in microbial associations with animal and plant hosts described using the gene ontology.

Authors:  Trudy Torto-Alalibo; Candace W Collmer; Michelle Gwinn-Giglio; Magdalen Lindeberg; Shaowu Meng; Marcus C Chibucos; Tsai-Tien Tseng; Jane Lomax; Bryan Biehl; Amelia Ireland; David Bird; Ralph A Dean; Jeremy D Glasner; Nicole Perna; Joao C Setubal; Alan Collmer; Brett M Tyler
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

8.  OTUD4 Is a Phospho-Activated K63 Deubiquitinase that Regulates MyD88-Dependent Signaling.

Authors:  Yu Zhao; Miranda C Mudge; Jennifer M Soll; Rachel B Rodrigues; Andrea K Byrum; Elizabeth A Schwarzkopf; Tara R Bradstreet; Steven P Gygi; Brian T Edelson; Nima Mosammaparast
Journal:  Mol Cell       Date:  2018-02-01       Impact factor: 17.970

9.  Caspase-8 acts as a molecular rheostat to limit RIPK1- and MyD88-mediated dendritic cell activation.

Authors:  Carla M Cuda; Alexander V Misharin; Angelica K Gierut; Rana Saber; G Kenneth Haines; Jack Hutcheson; Stephen M Hedrick; Chandra Mohan; G Scott Budinger; Christian Stehlik; Harris Perlman
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

10.  Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapy.

Authors:  Amanda Shanks Huynh; Woo Jin Chung; Hyun-Il Cho; Valerie E Moberg; Esteban Celis; David L Morse; Josef Vagner
Journal:  J Med Chem       Date:  2012-11-08       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.